Is a complete NSE/BIOFILCHEM research report available?

No complete published report is available for nse/BIOFILCHEM (NSE/BIOFILCHEM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/BIOFILCHEM (NSE/BIOFILCHEM)

National Stock Exchange of India: NSE/BIOFILCHEM · INR

₹34.4

-2.39 (-6.5%)· Recorded snapshot

Market cap	561.1M
Revenue (ttm)	346.3M
Net income (ttm)	4.8M
EPS (ttm)	₹0.30
P/E (trailing)	115.9x
Volume	173,268
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 346.3M
Net income (ttm): 4.8M
EPS (ttm): ₹0.30
P/E (trailing): 115.9x
Market cap: 561.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All NSE/BIOFILCHEM indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

INR

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	24
Employees Change	-2%
Employees Change Percent	-7.69
Enterprise value	INR 558.1M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.51
Industry PE Fwd	33.85
Isin	INE829A01014
Last refreshed	2026-09-12
Market cap	INR 561.1M
Price	INR 34.4
Price currency	INR
Rev Per Employee	14,427,375x
Sector	Healthcare
Sector PE	48.04
Sector PE Fwd	38.4
Sic	2834
Symbol	nse/BIOFILCHEM
Website	https://www.biofilgroup.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.86%
EV Earnings	115.28x
EV/EBIT	67.83x
EV/EBITDA	52.26x
EV/Sales	1.61x
FCF yield	-1.44%
P/B ratio	2.6x
P/E ratio	115.91x
P/S ratio	1.62x
PE Ratio10 Y	86.37x
PE Ratio3 Y	106.35x
PE Ratio5 Y	135.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.38%
EBITDA Margin	3.08%
Gross margin	7.17%
Gross Profit	INR 24.8M
Gross Profit Growth	-46.97%
Gross Profit Growth Q	-82.67%
Gross Profit Growth3 Y	4.2%
Gross Profit Growth5 Y	-12.34%
Net Income	INR 4.8M
Net Income Growth	-82.71%
Net Income Growth Q	-95.48%
Net Income Growth Qo Q	-48.61%
Net Income Growth Years	1%
Net Income Growth3 Y	-6.82%
Net Income Growth5 Y	-16.58%
Pretax Margin	2.37%
Profit Margin	1.4%
Profit Per Employee	INR 201,708
Profitable Quarters	INR 17
Profitable Years	17
Roa5y	1.52
Roe5y	5.67
ROIC	2.28
Roic5y	3.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.78%
Cagr3y	-10.7%
Cagr5y	-10.69%
EPS Growth	-82.57
EPS Growth Q	-95.27
EPS Growth Qo Q	-45.36
EPS Growth Years	1
EPS Growth3 Y	-0.83
EPS Growth5 Y	-16.58
Revenue Growth	1.26x
Revenue Growth Q	33.98x
Revenue Growth Qo Q	170.33x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	19.75x
Revenue Growth5 Y	-2.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 33.3M
Debt	INR 30.2M
Debt EBITDA	INR 2.83
Debt Equity	INR 0.14
Debt FCF	INR -3.75
Equity	INR 215.6M
Interest Coverage	548.5
Net Cash	INR 3.1M
Net Cash By Market Cap	INR 0.55
Net Debt EBITDA	INR -0.29
Net Debt Equity	INR -0.01
Tangible Book Value	INR 215.6M
Tangible Book Value Per Share	INR 13.21
WACC	7.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.77%
200-day SMA	33.34
3Y total return	-28.78%
50-day SMA	32.67
50-day SMA vs 200-day SMA	50under200
5Y total return	-43.17%
All Time High	356.1
All Time High Change	-89.89%
All Time High Date	2020-12-14
All Time Low	4.05
All Time Low Change	788.89%
All Time Low Date	2019-10-25
ATR	1.77
Beta	0.57
Ch YTD	7.24
High	37.8
High52	46.34
High52 Date	2026-02-04
High52ch	-25.77%
Low	32.36
Low52	25.6
Low52 Date	2026-03-30
Low52ch	34.38%
Ma50ch	10.21%
Price vs 200-day SMA	7.98%
RSI	73.91
RSI Monthly	45.19
RSI Weekly	57.83
Sharpe ratio	-0.11x
Sharpe Ratio3y	0.02x
Sharpe Ratio5y	-0.04x
Sortino ratio	-0.08
Sortino Ratio3y	0.16
Sortino Ratio5y	0.05
Total Return	0.8%
Tr YTD	7.24
Tr1m	11.15%
Tr1w	12.61%
Tr3m	-0.58%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,442,940%
Net Borrowing	25,487,000
Shares Insiders	17.25%
Shares Institutions	3.53%
Shares Qo Q	-4.52%
Shares Yo Y	-0.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	103,759.1x
Bv Per Share	13.21
CAPEX	INR -2M
Ch1m	11.15
Ch1w	12.61
Ch1y	-17.77
Ch3m	-0.58
Ch3y	-28.78
Ch5y	-43.17
Ch6m	19.6
Change	-6.5%
Change From Open	-8.99
Close	36.79
Days Gap	2.75
Depreciation Amortization	2,451,000
Dollar Volume	5,960,419.2
Earnings Date	2026-11-13
EBIT	INR 8.2M
EBITDA	INR 10.7M
EPS	INR 0.3
F Score	1
FCF	INR -8.1M
FCF EV Yield	-1.44x
Financing CF	25,386,000
Fiscal Year End	March
Founded	1,985
Graham Number	9.39569
Graham Upside	-72.69
Income Tax	INR 3.4M
Investing CF	11,374,000
Is Primary Listing	0
Last Earnings Date	2026-08-11
Last Report Date	2026-06-30
Lynch Fair Value	INR 1.48
Lynch Upside	-95.69
Ma150	33.23
Ma150ch	8.35%
Ma20	32.12
Ma20ch	12.07%
Net CF	30,711,000
Next Earnings Date	2026-11-13
Open	37.8
Position In Range	37.5
Price Date	2026-09-11
Price EBITDA	INR 52.55
Ptbv Ratio	2.6
Relative Volume	1.67x
Revenue	346,257,000x
Tax By Revenue	0.97x
Tax Rate	41.05%
Tr6m	19.6%
Volume	173,268

NSE/BIOFILCHEM (NSE/BIOFILCHEM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/BIOFILCHEM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/BIOFILCHEM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/BIOFILCHEM

Frequently asked questions